Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.57 |
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | PPARG | P37231 | 9/20 | 0.55 |
| ▸ | PARP1 | P09874 | 1/20 | 0.53 |
| ▸ | RXRA | P19793 | 1/20 | 0.52 |
| ▸ | MPC2 | O95563 | 2/20 | 0.51 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ciglitazone SCHEMBL20125581 | 1.00 | HPGD (1.00) | HPGDCYP3A4MAPTMEN1ALDH1A1 | |
| Ciglitazone SCHEMBL20125576 | 1.00 | HPGD (1.00) | HPGDCYP3A4MAPTMEN1ALDH1A1 | |
| Ciglitazone SCHEMBL21582134 | 0.99 | HPGD (0.98) | HPGDCYP3A4MAPTMEN1ALDH1A1 | |
| Ciglitazone SCHEMBL3189397 | 0.99 | HPGD (0.98) | HPGDCYP3A4MAPTMEN1ALDH1A1 | |
| Ciglitazone SCHEMBL8498957 | 0.94 | HPGD (0.89) | HPGDCYP3A4MAPTMEN1ALDH1A1 | |
| Ciglitazone SCHEMBL6203612 | 0.92 | HPGD (0.84) | HPGDCYP3A4MAPTMEN1ALDH1A1 | |
| SCHEMBL11091437 | 0.89 | CYP3A4 (0.81) | HPGDCYP3A4MAPTMEN1ALDH1A1 | |
| SCHEMBL11088249 | 0.88 | CYP3A4 (0.79) | HPGDCYP3A4MAPTMEN1ALDH1A1 | |
| SCHEMBL12521714 | 0.88 | HPGD (0.79) | HPGDCYP3A4MAPTMEN1ALDH1A1 | |
| SCHEMBL11083961 | 0.88 | CYP3A4 (0.78) | HPGDCYP3A4MAPTMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14525 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| EP-4683679-A1 | METHOD FOR DIAGNOSING AND TREATING NIS-EXPRESSING CARCINOMAS AND METASTASES | NUSKE, Andreas (DE) | 2026-01-28 | — | — | EP | claimed |
| EP-3452041-B1 | COMPOSITIONS AND METHODS FOR ADMINISTERING PPAR-GAMMA-AGONISTS, SURFACTANT PEPTIDES AND PHOSPHOLIPIDS | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT (US) | 2026-01-14 | — | — | EP | claimed |
| US-20250360215-A1 | PHARMACEUTICAL COMBINATIONS AND METHODS FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES | YUH CHIOU HWA (US) | 2025-11-27 | — | — | US | claimed |
| US-20250332101-A1 | Composition | CORDEIRO MARIA FRANCESCA (GB) | 2025-10-30 | — | — | US | claimed |
| EP-4640701-A2 | GLUCAGON LIKE PEPTIDE 1 (GLP-1) FUSION PEPTIDE COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE CONJUGATES AND USES THEREOF | Janssen Sciences Ireland Unlimited Company (IE) | 2025-10-29 | — | — | EP | claimed |
| EP-4635505-A1 | THERAPEUTIC AGENT FOR CHRONIC RESPIRATORY DISEASES | The Jikei University (JP) | 2025-10-22 | — | — | EP | claimed |
| US-20250281507-A1 | METHODS OF TREATING NEPHROTIC SYNDROME | THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN’S HOSPITAL | 2025-09-11 | — | — | US | claimed |
| EP-3787631-B1 | MODULATORS OF ORPHAN NUCLEAR RECEPTORS FOR NASH AND OTHER METABOLIC DISORDERS | UNIV EMORY (US) | 2025-09-10 | — | — | EP | claimed |
| US-20250221962-A1 | FABP4 AS A THERAPEUTIC TARGET IN SKIN DISEASES | TICURE LTD (IL) | 2025-07-10 | — | — | US | claimed |
| US-5457109-A | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus | WARNER-LAMBERT COMPANY (US) | 1995-10-10 | — | — | US | claimed |
| WO-1995007697-A2 | USE OF THIAZOLIDINEDIONE DERIVATIVES AND RELATED ANTIHYPERGLYCEMIC AGENTS IN THE TREATMENT OF DISEASE STATES AT RISK FOR PROGRESSING TO NONINSULIN-DEPENDENT DIABETES MELLITUS | WARNER-LAMBERT COMPANY (US) | 1995-03-23 | — | — | WO | claimed |
| WO-1995007694-A1 | USE OF THIAZOLIDINEDIONES TO PREVENT OR DELAY ONSET OF NIDDM | SANKYO COMPANY, LIMITED (JP) | 1995-03-23 | — | — | WO | claimed |
| US-5356913-A | Use of insulin sensitizing agents to treat hypertension | THE UPJOHN COMPANY (US) | 1994-10-18 | — | — | US | claimed |
| EP-0514452-B1 | USE OF INSULIN SENSITIZING AGENTS TO TREAT HYPERTENSION | THE UPJOHN COMPANY (US) | 1993-08-18 | — | — | EP | claimed |
| EP-0514452-A1 | USE OF INSULIN SENSITIZING AGENTS TO TREAT HYPERTENSION. | UPJOHN CO (US) | 1992-11-25 | — | — | EP | claimed |
| WO-1991012003-A1 | USE OF INSULIN SENSITIZING AGENTS TO TREAT HYPERTENSION | THE UPJOHN COMPANY (US) | 1991-08-22 | — | — | WO | claimed |
| EP-0008203-B1 | THIAZOLIDINE DERIVATIVES, PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | Takeda Chemical Industries, Ltd. (JP) | 1982-08-25 | — | — | EP | claimed |
| US-4287200-A | USEFUL AS REMEDIES FOR DIABETES AND HYPERLIPEMIA | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-09-01 | — | — | US | claimed |
| EP-0008203-A1 | Thiazolidine derivatives, preparing same and pharmaceutical compositions comprising same | Takeda Chemical Industries, Ltd. (JP) | 1980-02-20 | — | — | EP | claimed |